PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY

NCT03423199 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

180

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Palbociclib
DRUG: Placebo
DRUG: Tamoxifen
DRUG: Goserelin

Sponsor

National Cancer Center, Japan

Collaborators

[object Object]
[object Object]